Kevin M. Regan

1.7k total citations
19 papers, 1.3k citations indexed

About

Kevin M. Regan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Kevin M. Regan has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Kevin M. Regan's work include Prostate Cancer Treatment and Research (12 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Kevin M. Regan is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Kevin M. Regan collaborates with scholars based in United States, Germany and China. Kevin M. Regan's co-authors include Donald J. Tindall, Haojie Huang, Diping Wang, Jan M. A. van Deursen, Jeremy C. Smith, Fang Wang, Junjie Chen, Zhenkun Lou, Hannelore V. Heemers and Lucy J. Schmidt and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Kevin M. Regan

18 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin M. Regan United States 16 1.1k 341 240 230 220 19 1.3k
Yuriy Shostak United States 5 538 0.5× 630 1.8× 307 1.3× 211 0.9× 264 1.2× 9 1.1k
Jiadong Wang China 25 1.3k 1.2× 132 0.4× 529 2.2× 224 1.0× 137 0.6× 57 1.7k
Uta‐Maria Bauer Germany 17 1.7k 1.6× 149 0.4× 266 1.1× 147 0.6× 227 1.0× 28 2.0k
Yunguang Sun United States 20 948 0.9× 181 0.5× 439 1.8× 529 2.3× 116 0.5× 58 1.5k
Lovorka Stojic United Kingdom 18 1.3k 1.2× 56 0.2× 187 0.8× 536 2.3× 159 0.7× 22 1.6k
Anthony Tubbs United States 16 2.0k 1.9× 98 0.3× 677 2.8× 329 1.4× 202 0.9× 19 2.3k
Amanda S. Coutts United Kingdom 23 1.1k 1.0× 115 0.3× 451 1.9× 219 1.0× 310 1.4× 44 1.6k
Emilio Lecona Spain 21 1.2k 1.2× 94 0.3× 469 2.0× 208 0.9× 140 0.6× 34 1.5k
Renato Salemi Australia 15 944 0.9× 95 0.3× 397 1.7× 103 0.4× 74 0.3× 17 1.2k
Takehisa Matsumoto Japan 22 1.4k 1.3× 84 0.2× 288 1.2× 285 1.2× 162 0.7× 44 1.8k

Countries citing papers authored by Kevin M. Regan

Since Specialization
Citations

This map shows the geographic impact of Kevin M. Regan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Regan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Regan more than expected).

Fields of papers citing papers by Kevin M. Regan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin M. Regan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Regan. The network helps show where Kevin M. Regan may publish in the future.

Co-authorship network of co-authors of Kevin M. Regan

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Regan. A scholar is included among the top collaborators of Kevin M. Regan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Regan. Kevin M. Regan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wu, Chen, Lionel Aurelien Kankeu Fonkoua, Panwen Wang, et al.. (2024). 653 Phase I/II clinical trial for radiation and dendritic cell combination immunotherapy in patients with unresectable hepatocellular carcinoma and cholangiocarcinoma. Regular and Young Investigator Award Abstracts. A749–A750.
2.
Schroeder, Barbara, Ingrid Espinoza, Zeng Hu, et al.. (2021). Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells. Cell Death and Disease. 12(11). 977–977. 62 indexed citations
3.
Ding, Liya, Daiwen Chen, Ping Liu, et al.. (2014). CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy. Cancer Research. 74(7). 2050–2061. 35 indexed citations
4.
Ding, Liya, Yunqian Pan, Jian Zhong, et al.. (2014). CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy. 28 indexed citations
5.
Schmidt, Lucy J., Kelly Duncan, Neelu Yadav, et al.. (2012). RhoA as a Mediator of Clinically Relevant Androgen Action in Prostate Cancer Cells. Molecular Endocrinology. 26(5). 716–735. 45 indexed citations
6.
Lonergan, Peter E., Lucas P. Nacusi, Lucy J. Schmidt, et al.. (2012). Abstract 2924: Constitutively active androgen receptor splice variants function independently of full-length androgen receptor in a cell-based model of castrate-resistant prostate cancer. Cancer Research. 72(8_Supplement). 2924–2924. 11 indexed citations
7.
Heemers, Hannelore V., Lucy J. Schmidt, Zhifu Sun, et al.. (2011). Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer. Cancer Research. 71(5). 1978–1988. 35 indexed citations
8.
Jiang, Jingting, Yunqian Pan, Kevin M. Regan, et al.. (2011). Androgens repress expression of the f‐box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells. The Prostate. 72(2). 225–232. 17 indexed citations
9.
Heemers, Hannelore V., et al.. (2010). Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells. The Prostate. 70(9). 959–970. 21 indexed citations
10.
Heemers, Hannelore V., Kevin M. Regan, Lucy J. Schmidt, et al.. (2009). Androgen Modulation of Coregulator Expression in Prostate Cancer Cells. Molecular Endocrinology. 23(4). 572–583. 56 indexed citations
11.
Schmidt, Lucy J., Kevin M. Regan, S. Keith Anderson, et al.. (2009). Effects of the 5 alpha‐reductase inhibitor dutasteride on gene expression in prostate cancer xenografts. The Prostate. 69(16). 1730–1743. 16 indexed citations
12.
Fu, Zheng, Kevin M. Regan, Lizhi Zhang, et al.. (2009). Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice. Journal of Clinical Investigation. 119(9). 2714–24. 26 indexed citations
13.
Heemers, Hannelore V., Kevin M. Regan, Scott M. Dehm, & Donald J. Tindall. (2007). Androgen Induction of the Androgen Receptor Coactivator Four and a Half LIM Domain Protein-2: Evidence for a Role for Serum Response Factor in Prostate Cancer. Cancer Research. 67(21). 10592–10599. 53 indexed citations
14.
Dehm, Scott M., Kevin M. Regan, Lucy J. Schmidt, & Donald J. Tindall. (2007). Selective Role of an NH2-Terminal WxxLF Motif for Aberrant Androgen Receptor Activation in Androgen Depletion–Independent Prostate Cancer Cells. Cancer Research. 67(20). 10067–10077. 64 indexed citations
15.
Heemers, Hannelore V., Thomas J. Sebo, José D. Debes, et al.. (2007). Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells. Cancer Research. 67(7). 3422–3430. 82 indexed citations
16.
Heemers, Hannelore V., Kevin M. Regan, & Donald J. Tindall. (2007). Androgen induction of the androgen receptor co-activator FHL2 : Evidence for a role for serum response factor in prostate cancer. 67. 2 indexed citations
17.
Huang, Haojie, Kevin M. Regan, Zhenkun Lou, Junjie Chen, & Donald J. Tindall. (2006). CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage. Science. 314(5797). 294–297. 279 indexed citations
18.
Bakshi, Chandra Shekhar, Meenakshi Malik, Kevin M. Regan, et al.. (2006). Superoxide Dismutase B Gene (sodB)-Deficient Mutants ofFrancisella tularensisDemonstrate Hypersensitivity to Oxidative Stress and Attenuated Virulence. Journal of Bacteriology. 188(17). 6443–6448. 91 indexed citations
19.
Huang, Haojie, Kevin M. Regan, Fang Wang, et al.. (2005). Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proceedings of the National Academy of Sciences. 102(5). 1649–1654. 419 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026